205530
CA-074
CA-074, also referenced under CAS 134448-10-5, modulates the biological activity of cathepsin B. This small molecule/inhibitor is primarily used for Protease Inhibitors applications.
๋์์ด(๋ค):
CA-074, Cathepsin B Inhibitor III, [L-3- trans-(Propylcarbamoyl)oxirane-2-carbonyl]-L-isoleucyl-L-proline
์กฐ์ง ๋ฐ ๊ณ์ฝ ๊ฐ๊ฒฉ์ ๋ณด๋ ค๋ฉด ๋ก๊ทธ์ธ๋ฅผ ํด๋ฆญํฉ๋๋ค.
ํฌ๊ธฐ ์ ํ
์ ํ์ ๋ณด (DICE ๋ฐฐ์ก ์ ๋น์ฉ ๋ณ๋)
์คํ์(Hill ํ๊ธฐ๋ฒ):
C18H29N3O6
Molecular Weight:
383.44
NACRES:
NA.77
UNSPSC Code:
12352200
๊ธฐ์ ์๋น์ค
๋์์ด ํ์ํ์ ๊ฐ์? ์ ํฌ ์๋ จ๋ ๊ณผํ์ ํ์ด ๋์๋๋ฆฌ๊ฒ ์ต๋๋ค.
๋์ ๋ฌธ์๊ธฐ์ ์๋น์ค
๋์์ด ํ์ํ์ ๊ฐ์? ์ ํฌ ์๋ จ๋ ๊ณผํ์ ํ์ด ๋์๋๋ฆฌ๊ฒ ์ต๋๋ค.
๋์ ๋ฌธ์assay
≥98% (HPLC)
form
solid
manufacturer/tradename
Calbiochemยฎ
storage condition
OK to freeze
color
colorless to white
solubility
DMSO: 10 mg/mL
shipped in
ambient
storage temp.
−20ยฐC
Quality Level
๊ด๋ จ ์นดํ ๊ณ ๋ฆฌ
General description
A potent, irreversible inhibitor of Cathepsin B in vivo and in vitro (IC50 = 2.24 nM for rat liver cathepsin B).
An epoxysuccinyl peptide that acts as a potent, irreversible, and specific inhibitor of cathepsin B (IC50 = 2.24 nM for rat liver cathepsin B). Reduces ischemia-induced neuronal death. Exhibits lower membrane permeability when compared to CA-074 Me (Cat. No. 205531 ).
Biochem/physiol Actions
Cell permeable: no
Primary Target
cathepsin B
cathepsin B
Product does not compete with ATP.
Reversible: no
Target IC50: 2.24 nM for rat liver cathepsin B
Preparation Note
Following reconstitution, aliquot and freeze (-20ยฐC). Stock solutions are stable for up to 3 months at -20ยฐC.
Other Notes
Chan, V.J., et al. 1999. Biochem. J. 340, 113.
Tsuchiya, K., et al. 1999. Exp. Neurol. 155, 187.
Yamamoto, A., et al. 1997. J. Biochem.121, 974.
Inubushi, T., et al. 1994. J. Biochem. 116, 282.
Murata, M., et al. 1991. FEBS Lett. 280, 307.
Towatari, T., et al. 1991. FEBS Lett. 280, 311.
Tsuchiya, K., et al. 1999. Exp. Neurol. 155, 187.
Yamamoto, A., et al. 1997. J. Biochem.121, 974.
Inubushi, T., et al. 1994. J. Biochem. 116, 282.
Murata, M., et al. 1991. FEBS Lett. 280, 307.
Towatari, T., et al. 1991. FEBS Lett. 280, 311.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
์ ์ฅ ๋ฑ๊ธ
11 - Combustible Solids
wgk
WGK 3
์ํ ์ฑ์ ์(COA)
์ ํ์ ๋กํธ/๋ฐฐ์น ๋ฒํธ๋ฅผ ์ ๋ ฅํ์ฌ ์ํ ์ฑ์ ์(COA)์ ๊ฒ์ํ์ญ์์ค. ๋กํธ ๋ฐ ๋ฐฐ์น ๋ฒํธ๋ ์ ํ ๋ผ๋ฒจ์ ์๋ โ๋กํธโ ๋๋ โ๋ฐฐ์นโ๋ผ๋ ์ฉ์ด ๋ค์์ ์ฐพ์ ์ ์์ต๋๋ค.
์ด ์ ํ์ ์ด๋ฏธ ๊ฐ์ง๊ณ ๊ณ์ญ๋๊น?
๋ฌธ์ ๋ผ์ด๋ธ๋ฌ๋ฆฌ์์ ์ต๊ทผ์ ๊ตฌ๋งคํ ์ ํ์ ๋ํ ๋ฌธ์๋ฅผ ์ฐพ์๋ณด์ธ์.
Anneliese S Ashhurst et al.
bioRxiv : the preprint server for biology (2021-01-06)
The emergence of SARS-CoV-2 in late 2019, and the subsequent COVID-19 pandemic, has led to substantial mortality, together with mass global disruption. There is an urgent need for novel antiviral drugs for therapeutic or prophylactic application. Cathepsin L is a
Ananda Baral et al.
International journal of molecular sciences, 22(22) (2021-11-28)
Leptin, a hormone that is predominantly produced by adipose tissue, is closely associated with various liver diseases. However, there is a lack of understanding as to whether leptin directly induces cytotoxic effects in hepatocytes as well as the mechanisms that
๊ตญ์ ๋ฌด์ญ ํ๋ชฉ ๋ฒํธ
| SKU | GTIN |
|---|---|
| 205530-1MGCN | 04055977219616 |
์์ฌ์ ๊ณผํ์ํ์ ์๋ช ๊ณผํ, ์ฌ๋ฃ ๊ณผํ, ํํ ํฉ์ฑ, ํฌ๋ก๋งํ ๊ทธ๋ํผ, ๋ถ์ ๋ฐ ๊ธฐํ ๋ง์ ์์ญ์ ํฌํจํ ๋ชจ๋ ๊ณผํ ๋ถ์ผ์ ๊ฒฝํ์ด ์์ต๋๋ค..
๊ณ ๊ฐ์ง์ํ์ผ๋ก ์ฐ๋ฝ๋ฐ๋๋๋ค.